Upload
uttara
View
61
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Rangel QI Ironing out the kinks: Improving Screening and Treatment of Iron Deficiency Anemia. Betty Reyes, Taina Sanchez, PFA Staff Michelle Coleman, Clara Paris, RN Staff Wendy Acosta, Jessie Soriano, MA Staff Evelyn Berger, Hetty Cunningham, Christine Krause - PowerPoint PPT Presentation
Citation preview
Rangel QI Ironing out the kinks: Improving Screening and Treatment of Iron Deficiency Anemia
Betty Reyes, Taina Sanchez, PFA StaffBetty Reyes, Taina Sanchez, PFA StaffMichelle Coleman, Clara Paris, RN StaffMichelle Coleman, Clara Paris, RN StaffWendy Acosta, Jessie Soriano, MA StaffWendy Acosta, Jessie Soriano, MA Staff
Evelyn Berger, Hetty Cunningham, Christine Krause Evelyn Berger, Hetty Cunningham, Christine Krause Elshadey Bekele, Sandhya Brachio, Alicia Chang, Laura Perreta, Elshadey Bekele, Sandhya Brachio, Alicia Chang, Laura Perreta,
Wee Chua, Kenny McKinley, Jen Cohen, Andrew Wehrman, Wee Chua, Kenny McKinley, Jen Cohen, Andrew Wehrman, Ashish Ankola, Nisha Broodie, Ashley Blanchard, Pooja DesaiAshish Ankola, Nisha Broodie, Ashley Blanchard, Pooja Desai
Iron Deficiency
• Iron is the world’s most common single nutrient deficiency.
• Many studies have shown an association between iron deficiency and later cognitive deficits.
Iron Deficiency Anemia (IDA)
Bothwell TH et al. Oxford Blackwell Scientific 1979; 44-81
AIM Statement
• To standardize screening by sending CRP/ferritin and CBC levels in 9-month to 2.5 year olds (6% 80%)
• To improve treatment of iron deficiency (without anemia) in 9-month to 2.5-year olds. (0% 80%)
• Improve follow up by expediting prescriptions within one week (73% → 90%) and follow up labs within in one month (43% → 75%)
• Involve Rangel MAs and RNs in education of patients on high iron diets, iron deficiency and anemia
AAP 2010 Guidelines• Universal screening at 1 year • Selective screening at any age if risk factors present • Screening
• Serum Ferritin (SF) and C-Reactive Protein increase the sensitivity and specificity of the diagnosis
• Reticulocyte Hb (CHr) preferable biomarker• Establish a means of carefully tracking infants
identified as iron deficient.
Baker et al. Clinical Report- Diagnosis and Prevention of Iron Deficiency and Iron-Deficiency Anemia in Infants and Young Children (0-3 years of age). Pediatrics. 126(5): 1-11.
Rangel Baseline Data• Chart review: 50 patients(ages 9mo - 2y6mo)
•Screening rates• 37/37 (100%) patients >1y1mo with 1y screening CBC sent• 9/10 (90%) patients >2y1mo with 2y screening CBC sent• 3/48 (6%) patients had ferritin/CRP sent with screening labs
•Incidence• 7/37 (15%) 1 year olds anemic most recent CBC• 3/10 (30%) 2 year olds anemic on most recent CBC
•Treatment & Follow Up• 73% of patients received treatment within 1 week of lab result • Follow up appointments not standardized
•3/7 (43%) of patients followed up within 1 month
Intervention: Algorithm
Intervention: Posted Algorithm, Reminder Emails
Screening goal 80%
* % Iron Deficient without anemia
Interventions: Dietary screen
Dietary Screening Results• Results:
• Screens were given to PFAs to distribute in patient charts; however, very few patients were receiving them.
• 0/13 patients received the screening form in their charts
• Screening forms were given to MAs so that they could preferentially give the forms after vitals were taken to children coming in for WCC.
• 1/16 patients received the screen
● Most common symptom of Fe deficiency: Tiredness (90%)
● Take iron supplements with orange juice (80%), milk (60%)
● Nuts and meats are good sources of iron (50%)
● While only 10% identified having a child with anemia, 40% answered that they had been prescribed iron and 50% answered they gave the supplement daily
Intervention:Patient Survey (n=10)
• Providers responsible forFollowing up own labs
• If labs not cleared within2 weeks or unable to contactPatient/family, placed patient’sName in follow up binder
• RN Clara helps with Follow up & education of patients
Intervention:Follow Up Binder
February 2014 (n=15)Treatment & Follow up
TREATMENT FOLLOW UP
% Treated Average days until treatment
% Who followed up
Average days until follow up
IDA 100% (3/3)
4.7 66% (2/3) 78
ID without anemia
100% (5/5)
2.7 40% (2/5) 64
Anemia without ID
25% (1/4) 9 0% 0
Anemia with normal
ferritin/high CRP
33% (1/3) 7 33% (1/3) 163
• Successfully utilized Ferritin and CRP as screening labs for Fe deficiency in our high-risk population
• Increased rate of Ferritin/CRP screening from 6% → 92% (target: 80%)
• Increased rate of treating ID without IDA from 0→ 100% (target: 80%)
• Increased appropriate prescription within 1 week from 73% → 100% (target: 90%)
• Decreased anemia follow up within in one month from 43% → 6% (target 75%)
Results
Lessons We Learned….
• Barriers to Change• Screening tools hard to incorporate into work flow, Follow up
hurdles, time (PDSA cycles)
• Applicable to Other ACN Clinics?• YES!
• Next Steps…• Patient Survey and Education, System changes to improve
follow up, Other possible tests
Thank You!!!